We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
+11.64%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$30.3B
AUM Growth
+$3.04B
Cap. Flow
+$511M
Cap. Flow %
1.68%
Top 10 Hldgs %
23.4%
Holding
1,366
New
72
Increased
362
Reduced
521
Closed
85

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$231M
2
CMCSA icon
Comcast
CMCSA
+$178M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$133M
4
BABA icon
Alibaba
BABA
+$111M
5
INTC icon
Intel
INTC
+$103M

Sector Composition

Rank Sector Weight
1 Technology 30.06%
2 Healthcare 18.45%
3 Financials 13.5%
4 Consumer Discretionary 11.41%
5 Communication Services 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXM icon
1226
Oxford Industries
OXM
$560M
$24K ﹤0.01%
+237
New +$23.1K
LW icon
1227
Lamb Weston
LW
$7.16B
$18K ﹤0.01%
277
-14,984
-98% -$864K
GOTU icon
1228
Gaotu Techedu
GOTU
$453M
$17K ﹤0.01%
8,871
LYLT
1229
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$8K ﹤0.01%
+266
New +$8.59K
AGRO icon
1230
Adecoagro
AGRO
$1.35B
$5K ﹤0.01%
605
-2,393
-80% -$20.3K
ADAP
1231
DELISTED
Adaptimmune Therapeutics
ADAP
-45,900
Closed -$237K
APO icon
1232
Apollo Global Management
APO
$73.7B
-22,343
Closed -$1.38M
AQB icon
1233
AquaBounty Technologies
AQB
$5.51M
-3,575
Closed -$291K
ARWR icon
1234
Arrowhead Research
ARWR
$12.1B
-2,655
Closed -$166K
AXTA icon
1235
Axalta
AXTA
$8.03B
-2,833
Closed -$83K
AZTA icon
1236
Azenta
AZTA
$1.42B
-2,608
Closed -$267K
BANF icon
1237
BancFirst
BANF
$3.81B
-2,332
Closed -$140K
BCYC
1238
Bicycle Therapeutics
BCYC
$278M
-3,750
Closed -$156K
BHE icon
1239
Benchmark Electronics
BHE
$2.96B
-18,996
Closed -$507K
BLFS icon
1240
BioLife Solutions
BLFS
$1.66B
-1,100
Closed -$47K
BLUE
1241
DELISTED
bluebird bio
BLUE
-234
Closed -$58K
CBUS icon
1242
Cibus
CBUS
$143M
-904
Closed -$182K
CLB icon
1243
Core Laboratories
CLB
$513M
-14,303
Closed -$397K
CRSP icon
1244
CRISPR Therapeutics
CRSP
$4.99B
-600
Closed -$67K
DHX icon
1245
DHI Group
DHX
$178M
-370,174
Closed -$1.76M
DTM icon
1246
DT Midstream
DTM
$13.6B
-2,307
Closed -$107K
EBS icon
1247
Emergent Biosolutions
EBS
$274M
-471
Closed -$24K
EDIT icon
1248
Editas Medicine
EDIT
$445M
-2,250
Closed -$92K
EPD icon
1249
Enterprise Products Partners
EPD
$82.3B
-2,600
Closed -$56K
EPR icon
1250
EPR Properties
EPR
$4.7B
-375
Closed -$19K

Similar funds

KBC Group's Q4 2021 Portfolio in Review

As of Q4 2021, KBC Group held 1,366 positions worth $30.3B, up 11% from $27.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

KBC Group's Q4 2021 filing shows 72 new, 362 increased, 521 reduced and 85 closed positions. Its largest new stake was Olaplex Holdings: 327,615 shares worth $9.54M. The largest sale was JPMorgan Chase, an estimated $231M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • KBC Group's largest Q4 2021 buy was Olaplex Holdings: 327,615 shares worth $9.54M.
  • KBC Group added most to Nike in Q4 2021, an estimated $162M increase.
  • KBC Group's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $231M.
  • KBC Group fully exited SPX Corp in Q4 2021, selling an estimated $20.3M.
  • KBC Group's ten largest holdings make up 23% of its $30.3B portfolio in Q4 2021.
  • KBC Group opened 72 new positions and closed 85 in Q4 2021.
  • KBC Group's portfolio value rose 11% quarter-over-quarter to $30.3B.

Based on KBC Group's 13F filing for Q4 2021, filed 3 Feb 2022.